Team uncovers promising lead in genetic approach to treating glioblastoma

by Anna C. Christensen,University of ArizonaBaldassarre Stea, MD, PhD, (center), treats brain tumors with DNA-damaging radiation. Credit: Anna C. ChristensenGlioblastoma, a deadly brain cancer t

Updated on: May 27,2024

Team uncovers promising lead in genetic approach to treating glioblastoma

by Anna C. Christensen,University of ArizonaBaldassarre Stea, MD, PhD, (center), treats brain tumors with DNA-damaging radiation. Credit: Anna C. ChristensenGlioblastoma, a deadly brain cancer t

Updated on:May 27,2024

Researchers identify link between cancer-causing gene and aging

by University of PittsburghMice lacking the gene Myc (left) have greyer coats and other signs of advanced aging compared to normal mice (right) of the same age. Credit: Taylor StevensA gene calle

Updated on: February 23,2024

Researchers identify link between cancer-causing gene and aging

by University of PittsburghMice lacking the gene Myc (left) have greyer coats and other signs of advanced aging compared to normal mice (right) of the same age. Credit: Taylor StevensA gene calle

Updated on:February 23,2024

A common genetic signature has been discovered among three cancer prone rare skin diseases

by Carlos III University of MadridGene expression signature in fibroblasts from RDEB, KS and XPC patients, compared to healthy donors (a). An alteration common to the three diseases of 227 genes

Updated on: April 22,2024

A common genetic signature has been discovered among three cancer prone rare skin diseases

by Carlos III University of MadridGene expression signature in fibroblasts from RDEB, KS and XPC patients, compared to healthy donors (a). An alteration common to the three diseases of 227 genes

Updated on:April 22,2024

Triplet therapy including belamaf prolongs survival in multiple myeloma

by Elana GotkineFor patients with relapsed or refractory multiple myeloma (RRMM), triplet therapy of belantamab mafodotin (belamaf) plus bortezomib and dexamethasone (BVd) improves outcomes, with an a

Updated on: March 24,2024

Triplet therapy including belamaf prolongs survival in multiple myeloma

by Elana GotkineFor patients with relapsed or refractory multiple myeloma (RRMM), triplet therapy of belantamab mafodotin (belamaf) plus bortezomib and dexamethasone (BVd) improves outcomes, with an a

Updated on:March 24,2024

Researchers develop tool to measure patient health and well-being after radionuclide therapy

by H. Lee Moffitt Cancer Center & Research InstituteGraphical abstract. Credit:Journal of Nuclear Medicine(2023). DOI: 10.2967/jnumed.122.264946Cancer is a devasting disease that

Updated on: February 03,2024

Researchers develop tool to measure patient health and well-being after radionuclide therapy

by H. Lee Moffitt Cancer Center & Research InstituteGraphical abstract. Credit:Journal of Nuclear Medicine(2023). DOI: 10.2967/jnumed.122.264946Cancer is a devasting disease that

Updated on:February 03,2024

Study finds use of methotrexate is associated with an increased risk of skin cancer

byUniversity of GothenburgRisk of basal cell carcinoma, cutaneous squamous cell carcinoma, and cutaneous malignant melanoma according to cumulative methotrexate dose for all patients. BCC basal

Updated on: January 23,2024

Study finds use of methotrexate is associated with an increased risk of skin cancer

byUniversity of GothenburgRisk of basal cell carcinoma, cutaneous squamous cell carcinoma, and cutaneous malignant melanoma according to cumulative methotrexate dose for all patients. BCC basal

Updated on:January 23,2024

Study finds 5-year relative survival rate of 59.6 percent in lower-risk myelodysplastic syndromes

by Elana Gotkine HealthDay ReporterAbout 40 percent of patients with lower-risk myelodysplastic syndromes (LR-MDS) die of MDS within five years, according to a study published online Nov. 6 in the&nbs

Updated on: January 23,2024

Study finds 5-year relative survival rate of 59.6 percent in lower-risk myelodysplastic syndromes

by Elana Gotkine HealthDay ReporterAbout 40 percent of patients with lower-risk myelodysplastic syndromes (LR-MDS) die of MDS within five years, according to a study published online Nov. 6 in the&nbs

Updated on:January 23,2024

Spiritual themes, distrust may factor into Black patients' reluctance to participate in cancer clinical trials

byAmerican Society for Radiation OncologyCredit: CC0 Public DomainSpiritual beliefs and a historically-based distrust of clinical research may factor into Black patients' decisions about whe

Updated on: October 22,2024

Spiritual themes, distrust may factor into Black patients' reluctance to participate in cancer clinical trials

byAmerican Society for Radiation OncologyCredit: CC0 Public DomainSpiritual beliefs and a historically-based distrust of clinical research may factor into Black patients' decisions about whe

Updated on:October 22,2024

Research reveals Orkney cancer gene link—now testing will take place

byUniversity of AberdeenOutline pedigree of two kindreds (A and B) from the ORCADES study. Filled circles are breast or ovarian cancers, red outlines are sequenced V1736A carriers, dotted red ou

Updated on: January 16,2024

Research reveals Orkney cancer gene link—now testing will take place

byUniversity of AberdeenOutline pedigree of two kindreds (A and B) from the ORCADES study. Filled circles are breast or ovarian cancers, red outlines are sequenced V1736A carriers, dotted red ou

Updated on:January 16,2024

Sex differences identified in deadly brain tumors

by Washington University School of MedicineGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0For decades, scientists have recognized that more males get cancer and die of the disease

Updated on: April 20,2024

Sex differences identified in deadly brain tumors

by Washington University School of MedicineGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0For decades, scientists have recognized that more males get cancer and die of the disease

Updated on:April 20,2024

New study targets major risk factor for gastric cancer

by University of Miami Leonard M. Miller School of MedicineCredit: CC0 Public DomainWhat if we could eliminate a major risk factor for stomach cancer in Black, Asian, Latino and other vulnerable

Updated on: April 06,2024

New study targets major risk factor for gastric cancer

by University of Miami Leonard M. Miller School of MedicineCredit: CC0 Public DomainWhat if we could eliminate a major risk factor for stomach cancer in Black, Asian, Latino and other vulnerable

Updated on:April 06,2024

AI facilitates breakthrough in sinonasal cancer diagnostics

byLudwig Maximilian University of MunichMethylation array for the determination of DNA modifications. Credit: Jurmeister et al.Although tumors in the nasal cavity and the paranasal sinus are con

Updated on: January 02,2024

AI facilitates breakthrough in sinonasal cancer diagnostics

byLudwig Maximilian University of MunichMethylation array for the determination of DNA modifications. Credit: Jurmeister et al.Although tumors in the nasal cavity and the paranasal sinus are con

Updated on:January 02,2024